Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. ENLV
ENLV logo

ENLV Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Enlivex Ltd (ENLV) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.120
1 Day change
-3.45%
52 Week Range
2.100
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Enlivex Ltd (ENLV) is not a strong buy at the moment given the user's long-term investment strategy and beginner level. The stock shows weak financial performance, no significant positive catalysts, and lacks clear upward momentum. It is better to hold off on investing in this stock until stronger signals or catalysts emerge.

Technical Analysis

The technical indicators are mixed. The MACD is negative and expanding downward, suggesting bearish momentum. RSI is neutral at 47.594, showing no clear trend. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the stock is trading below key support levels (S1: 1.028). Overall, the technical picture is unclear with a slight bearish bias.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The options data indicates low put activity relative to calls, suggesting limited bearish sentiment. However, the low volume and open interest overall do not provide strong trading sentiment signals.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
6

Positive Catalysts

  • NULL. No recent news, no significant insider or hedge fund activity, and no congress trading data available.

Neutral/Negative Catalysts

  • The stock has shown consistent declines in the regular market (-6.67%) and pre/post-market trading. Financial performance is weak, with declining net income (-15.26% YoY) and EPS (-25% YoY). No news or events to drive positive sentiment.

Financial Performance

In Q3 2025, the company reported no revenue growth (0% YoY) and a significant drop in net income (-15.26% YoY) and EPS (-25% YoY). Gross margin remains at 0%. The financials indicate poor performance with no signs of growth.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst ratings or price target changes available for ENLV. Lack of coverage may indicate limited interest or confidence in the stock.

Wall Street analysts forecast ENLV stock price to rise
2 Analyst Rating
Wall Street analysts forecast ENLV stock price to rise
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 1.160
sliders
Low
13
Averages
13
High
13
Current: 1.160
sliders
Low
13
Averages
13
High
13
D. Boral Capital
D. Boral Capital
Buy -> Hold
downgrade
AI Analysis
2025-11-24
Reason
D. Boral Capital
D. Boral Capital
Price Target
AI Analysis
2025-11-24
downgrade
Buy -> Hold
Reason
D. Boral Capital downgraded Enlivex Therapeutics to Hold from Buy with no price target after the company announced a $212M private placement for 212M shares priced at $1.00 to initiate a digital asset treasury strategy centered on the accumulation of RAIN tokens designed for on-chain predictive markets, options trading, and transparent data aggregation. The firm, which notes its valuation models had been based on the value of the therapeutic, says those are "less relevant now" and it needs some time to understand how to value the company following the shift.
D. Boral Capital
Jason Kolbert
Strong Buy
Maintains
$13
2025-04-21
Reason
D. Boral Capital
Jason Kolbert
Price Target
$13
2025-04-21
Maintains
Strong Buy
Reason

People Also Watch